Episode

New Thinking: Big Pharma w/ Owain Williams

Podcast
SPERI Presents...
Published
Apr 23, 2025
Duration seconds
2268
Processing state
not_requested
Canonical source
https://shows.acast.com/speri-presents/episodes/new-thinking-big-pharma
Audio
https://sphinx.acast.com/p/open/s/6683f98604b201dd34f20976/e/67f63f190c09f662024ae294/media.mp3
JSON
/v1/public/podcasts/speri-presents-7048864/episodes/new-thinking-big-pharma-w-owain-williams
Markdown
/podcast/speri-presents-7048864/new-thinking-big-pharma-w-owain-williams.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/speri-presents-7048864/episodes/new-thinking-big-pharma-w-owain-williams/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/speri-presents-7048864/new-thinking-big-pharma-w-owain-williams.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

A tiny number of huge companies dominate the pharmaceutical industry, making extraordinary profits in the process. All the while, the poorest people around the world struggle to access medicines they need to survive. What does the COVID-19 pandemic tell us about Big Pharma? What's the problem with a cartelized global market? What role does Bill Gates play in solving (or reproducing) the big challenges of global health? Is there a political economy explanation for rising anti-vaccine sentiment? Should we expect Trump's second Presidency to challenge the dominance of Big Pharma? Dr Owain Williams is a Senior Research Fellow at the Commercial and Economic Determinants of Health Research Translation Centre at Deakin University in Melbourne, Australia and a Visiting Associate Professor in Global Political Economy and Health at University of Leeds. Professor Simon Rushton is Professor of International Politics at University of Sheffield. They join Dr Remi Edwards to discuss Owain's recent co-authored paper COVID and structural cartelisation: market-state-society ties and the political economy of Pharma (2024). They consider the relationship between states and big pharmaceutical firms; the role of philanthropic-capitalist organisations like the Gates Foundation in global health governance; how effective (or not) markets are in delivering welfare goods like vaccinations; and the rise of vaccine hesitancy across the political spectrum. 'New Thinking in Political Economy' is a monthly podcast showcasing cutting-edge political economy research that helps us to understand the world around us. This episode is produced by the SPERI Presents… committee, including Remi Edwards, Chris Saltmarsh, Frank Maracchione, Emma Mahoney, Dillon Wamsley and Andrew Hindmoor. This episode was edite…